Skip to main content
OpenTrials
Completed

NCT Number: NCT02391103

Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery

The purposes of this study are 1) to determine whether neuromuscular electrical stimulation (NMES) is effective in preventing loss of muscle mass and strength and 2) to observe the time variation of MLT and strength from preoperative day to hospital discharge.

Completed

Looking for future studies?

Notify Me

Key information

About this study

In the amendment of June 2011, a twofold study setting was defined in order to recruit patients not only before, but also after cardiothoracic surgery. In sample A, patients were recruited before surgery. In sample B, patients were recruited after surgery. On postoperative day 1, randomization was performed for sample A and B separately. To ensure balance of the NMES and control groups with respect to disease severity, randomization was stratified by the SAPS II score on the first postoperative day. In the intervention group, the anterior muscles of both thighs were electrically stimulated from the first postoperative day until ICU discharge for a maximum of 14 days. In the control group, the electrodes were applied, but no electricity was delivered.The primary outcomes muscle layer thickness (MLT) and muscle strength were assessed from the first postoperative day to ICU discharge and at hospital discharge. All patients in sample A had an additional assessment of MLT and strength before surgery.

All data are analyzed according to the intention-to-treat principle with no imputation for any missing data. Linear mixed models are used to account for the repeated measurements per patient and to determine any fixed effects on MLT and MRC score.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients before/after cardiothoracic surgery
  • ICU stay > 48 hours

Exclusion criteria

  • body mass index > 40 kg/m2
  • severe leg swelling
  • implanted ventricular assist device (RVAD, LVAD, BiVAD)
  • implanted intra-aortic balloon pump (IABP)
  • neuromuscular diseases
  • skin lesions in stimulation area
  • leg excluded if implant (hip or knee replacement) in stimulation area

Treatment and study plan

Compex 3 Professional (CefarCompex Medical AB) stimulator

Device

NMES

sham-stimulation

Device

no electricity applied

Primary outcomes

  1. Muscle layer thickness (MLT)

    Time frame: on preoperative day, from postoperative day 1 onwards every other ICU day for the duration of the ICU stay (expected average of ICU stay: 7 days) and at day of hospital discharge (expected average of hospital stay: 20 days)

    Muscle layer thickness of the anterior muscles of the thigh using two-dimensional B-mode ultrasound

  2. Muscle strength

    Time frame: on preoperative day, from postoperative day 1 onwards every day for the duration of the ICU stay (expected average of ICU stay: 7 days), at day of hospital discharge (expected average of hospital stay: 20 days)

    Muscle strength using Medical Research Council (MRC) score and hand dynamometry

Secondary outcomes

  1. JAGS score

    Time frame: on preoperative day, on day of ICU discharge (expected average of ICU stay: 7 days), on day of hospital discharge (expected average of hospital stay: 20 days)

    JAGS score

  2. Timed Up and Go test

    Time frame: on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)

    Timed Get Up and Go test

  3. FIM score

    Time frame: on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)

    Functional Independance Measure (FIM) score

  4. SF-12 score

    Time frame: on preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)

    12-item Short Form Health Survey (SF-12)

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery. An Ultrasound-Based Randomized Controlled Trial

Acronym: Catastim 2

Important dates

Study start
2011
Primary completion
2012
Study completion
2015
First posted
Mar 18, 2015
Registry last updated
Jul 8, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.